Ironwood Pharmaceuticals ...

NASDAQ: IRWD · Real-Time Price · USD
1.07
-0.02 (-1.83%)
At close: Aug 14, 2025, 3:59 PM
1.09
1.40%
Pre-market: Aug 15, 2025, 09:00 AM EDT

Ironwood Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
880K -1B 175.06M 528.45M
Depreciation & Amortization
2.01M 1.57M 1.42M 1.52M
Stock-Based Compensation
29.85M 32.01M 27.05M 22.28M
Other Working Capital
-26.29M -2.02M 2.94M 12.66M
Other Non-Cash Items
1.98M 1.07B 1.67M 25.21M
Deferred Income Tax
68.09M 72.64M 65.74M -333.29M
Change in Working Capital
739K 11.28M 2.82M 17.73M
Operating Cash Flow
103.55M 183.43M 273.76M 261.89M
Capital Expenditures
-142K -273K -136K -265K
Cash Acquisitions
n/a -1.03B n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-142K -1.03B -136K -265K
Debt Repayment
-115M 300M -120.7M n/a
Common Stock Repurchased
n/a n/a -126.39M -24.13M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.98M -29.2M 9.54M 19.58M
Financial Cash Flow
-106.97M 277.16M -237.55M -4.55M
Net Cash Flow
-3.6M -565.78M 36.07M 257.08M
Free Cash Flow
103.41M 183.15M 273.63M 261.63M